ATXI
Avenue Therapeutics, Inc. Common Stock
ATXI
ATXI
Delisted
ATXI was delisted on the 18th of March, 2025.
6 hedge funds and large institutions have $890K invested in Avenue Therapeutics, Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 1 closing their positions.
Holders
6
Holders Change
–
Holders Change %
0%
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$427K |
| 2 |
FWM
2
Frontier Wealth Management
Kansas City,
Missouri
|
$90K |
| 3 |
BRWA
3
B. Riley Wealth Advisors
Boca Raton,
Florida
|
$281K |
Top Sellers
| 1 |
VF
1
Virtu Financial
New York
|
$0 |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$17K |
| 3 |
3
BlackRock
New York
|
$75K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Vanguard Group
Malvern,
Pennsylvania
| $427K | 94,726 | +50,534 | +114% |
|
|
BRWA
2
B. Riley Wealth Advisors
Boca Raton,
Florida
| $281K | 62,250 | +6,750 | +12% |
|
|
FWM
3
Frontier Wealth Management
Kansas City,
Missouri
| $90K | 20,000 | +20,000 | New |
|
|
4
BlackRock
New York
| $75K | 16,640 | -425 | -2% |
|
|
5
UBS Group
Zurich,
Switzerland
| $17K | 3,818 | -5,947 | -61% |
|
|
VF
6
Virtu Financial
New York
| – | – | -15,917 | Closed |
|
7
Morgan Stanley
New York
| $0 | 10 | -11 | -52% |
|